First human tests: is new drug ITI-333 safe?
NCT ID NCT05732194
Summary
This was an early, small study to check the safety of a new drug called ITI-333 and see how the body processes it. It involved 32 healthy volunteers who took the drug or a placebo (a dummy pill) daily for two weeks. The main goal was to find out if the drug was safe and well-tolerated, and to measure its levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 1
Miami, Florida, 33014-3616, United States
Conditions
Explore the condition pages connected to this study.